Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

German scientists synthesize novel apoptosis-inducing agents

June 26, 1998

Verapamil prodrug enhances activity of cytotoxic agents in resistant cell lines

June 26, 1998

Interim report on phase I testing of bizelesin, a bifunctional alkylating agent

June 26, 1998

Genta to commence phase I/IIa trial with G-3139

June 26, 1998

Megabios seeks partners for oncology programs

June 26, 1998

Pharmacokinetics and metabolism of TAT-59 investigated in animals

June 25, 1998

Broadened use of Taxotere in breast cancer cleared by FDA

June 25, 1998

Flavone acetic acid analogue suppresses tumor blood perfusion, patient study shows

June 25, 1998

First patients being treated with bombesin/GRP antagonist RC-3095

June 25, 1998

Cationic peptides exert selective antitumor activity against sensitive and resistant cell lines

June 25, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...